http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-241271-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_562addd58040b9744a8872c699f364de |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54 |
| filingDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_721919e61da96c6561b7fedf5cc5ec38 |
| publicationDate | 2022-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PL-241271-B1 |
| titleOfInvention | The combination of the lupane triterpene compound for the prevention and treatment of Alzheimer's disease |
| abstract | The subject of the invention is the use of a compound of the pentacyclic triterpenes having a neuroprotective effect and defined by formula 1, in which the radicals R1 are the same or different and are selected from the group consisting of: -OH, -COOH, -Me, -Et, -Bn, -C≡ N, -NH2, -C (= O) CH3, -CH2OH for the manufacture of a medicament for the prevention and treatment of Alzheimer's disease, the manufactured medicament containing an effective amount of the compound. Moreover, the subject of the application is also a pharmaceutical composition containing at least one of the compounds represented by the general formula 1. |
| priorityDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 260.